Silventum Overview

  • Founded
  • 2017
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Investors
  • 2

Silventum General Information


Developer of a dental therapy device intended to focus on development of dental filling materials. The company's dental filling materials assist in providing resistance from bacterial infection with mechanical, structural and aesthetic qualities, enabling patients to receive dental filling products that prevents dental decay or cavities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • Otago Innovation Limited, Centre For Innovation
  • 87 Saint David Street
  • Dunedin, 9054
  • New Zealand
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Silventum Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 22-Dec-2017 Completed Startup
To view Silventum’s complete valuation and funding history, request access »

Silventum Executive Team (2)

Name Title Board Seat Contact Info
Gemma Cotton Ph.D Co-Founder & Chief Technology Officer
Carla Meledandri Ph.D Co-Founder & Chief Scientific Officer
To view Silventum’s complete executive team members history, request access »

Silventum Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Powerhouse Ventures (Christchurch) Venture Capital Minority 000 0000 000000 0
University of Otago Accelerator/Incubator Minority 000 0000 000000 0
To view Silventum’s complete investors history, request access »